INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
INTENSITY THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.29−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- $8.90M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$11.97MFY2025